EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewOpen Access · CC BY 4.0

Clinical Outcome Assessments in Movement Disorders: A Scoping Review of Current Rating Scales and Future Needs Beyond Parkinson's Disease

Panagiota Tsitsi iD, Evita Papathoma iD, Nirosen Vijiaratnam iD, Camila Aquino iD, Stephen R Duma iD, Norbert Kovacs, Kigocha Lameck Okeng'o iD, Aparna Wagle Shukla iD, Roongroj Bhidayasiri iD, Alberto J Espay iD, Tiago A Mestre iD, Alvaro Sanchez Ferro iD und 3 weitere

Movement Disorders Clinical Practice · 06.11.2026

DOI: 10.1002/mdc3.70890 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 06.11.2026. Verfasst von Panagiota Tsitsi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Die Arbeit nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical outcome assessments (COA) are essential for evaluating symptom severity, treatment response, and disease progression in movement disorders. As clinical knowledge evolves, it is necessary to ensure COAs continued relevance and validity.

Objectives

The aims were to provide an updated overview of existing Movement Disorder Society (MDS)–recommended COAs in movement disorders and to identify specific constructs or COAs requiring further revision or validation to inform current clinical practice and research.

Methods

The Scientific Evaluation Committee of the MDS‐COA program commissioned a position paper on the current evidentiary state of COAs. A panel of experts conducted a 2‐step review: first, extracting data from previous MDS publications on COA appraisals using a standardized template; second, conducting a scoping review up to May 2026 to identify new COAs or updated validation data in movement disorders. All study designs were considered.

Results

Of the 13 constructs identified in movement disorders other than PD, updated reviews are most urgently warranted for tremor and dystonia, given the volume of new evidence, emergence of novel instruments, and expanding therapeutic options. For all remaining constructs, important advances were identified alongside persistent gaps in validation, longitudinal data, and clinical interpretability.

Conclusions

The principal challenge in movement‐disorder outcome assessment has shifted from developing new instruments to establishing their comparative validity, responsiveness, and clinical interpretability. Tremor and dystonia have accumulated sufficient new evidence to justify updated MDS reviews, whereas across all constructs the major unmet needs are harmonization of existing measures, longitudinal validation, and integration of patient‐reported and digital outcomes into clinically meaningful assessment frameworks.

Schlagwörter

Stichwörter der Autor:innen

clinical outcome assessmentdystoniamovement disorderspsychometricstremor

Autor:innen und Institutionen

  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Department of Neurology, Onze-Lieve-Vrouw Hospital, Aalst, Belgium.
  • Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Neurology, Monash Health, Melbourne, VIC, Australia.
  • Clinical Research Centre for Movement Disorders and Gait, Kingston Centre, Parkinson's Foundation Centre of Excellence, Monash Health, Melbourne, VIC, Australia.
  • Department of Clinical Neurosciences, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

ORCID-Profile: Panagiota Tsitsi, Evita Papathoma, Nirosen Vijiaratnam, Camila Aquino, Stephen R Duma, Kigocha Lameck Okeng'o, Aparna Wagle Shukla, Roongroj Bhidayasiri, Alberto J Espay, Tiago A Mestre, Alvaro Sanchez Ferro, Michelle H S Tosin, Matej Skorvanek, Ioanna Markaki

Zitieren

APA

Tsitsi, P., Papathoma, E., Vijiaratnam, N., Aquino, C., Duma, S. R., Kovacs, N., Okeng'o, K. L., Wagle Shukla, A., Bhidayasiri, R., Espay, A. J., Mestre, T. A., Ferro, A. S., Tosin, M. H. S., Skorvanek, M., & Markaki, I. (2026). Clinical Outcome Assessments in Movement Disorders: A Scoping Review of Current Rating Scales and Future Needs Beyond Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70890

Vancouver

Tsitsi P, Papathoma E, Vijiaratnam N, Aquino C, Duma SR, Kovacs N, et al. Clinical Outcome Assessments in Movement Disorders: A Scoping Review of Current Rating Scales and Future Needs Beyond Parkinson's Disease. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70890

BibTeX
@article{Tsitsi2026,
  author = {Tsitsi, Panagiota and Papathoma, Evita and Vijiaratnam, Nirosen and Aquino, Camila and Duma, Stephen R and Kovacs, Norbert and Okeng'o, Kigocha Lameck and Wagle Shukla, Aparna and Bhidayasiri, Roongroj and Espay, Alberto J and Mestre, Tiago A and Ferro, Alvaro Sanchez and Tosin, Michelle H S and Skorvanek, Matej and Markaki, Ioanna},
  title = {Clinical Outcome Assessments in Movement Disorders: A Scoping Review of Current Rating Scales and Future Needs Beyond Parkinson's Disease},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  doi = {10.1002/mdc3.70890}
}
Kostenlos starten →